Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.

The relationship between RAC3 expression and clinical outcome in bladder cancer (BLCA) was uncertain. In this study, the expression level of RAC3 in BLCA and its clinical outcome were analyzed through various independent public databases. The mRNA expression level of RAC3 in BLCA and normal bladder was evaluated from the Gene Expression Omnibus (GEO), Oncomine, and The Cancer Genome Atlas (TCGA) database.

Expression patterns and a prognostic model of mA-associated regulators in prostate adenocarcinoma.

To study the expression patterns and prognostic value of the mA-associated regulators in prostate adenocarcinoma (PRAD). The mRNA expression and clinical data were downloaded from 'The Cancer Genome Atlas database'. The mA-associated variants were downloaded from mAVar database, and combined with 14 common mA regulators for subsequent analysis.